Evaluates rifaximin regimens' effectiveness in managing liver cirrhosis and predicting disease outcomes.
This study is focused on efficiency of various rifaximin-α regimens in order to optimize the treatment and preventive approaches for cirrhosis of the liver with minimal hepatic encephalopathy, as well as to predict the course of the disease and the risk of complications.
No takes yet. Share an insight, caveat, or question.
BAKULIN et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: